Studies published in 2013 have addressed the question of whether the rising incidence of differentiated thyroid cancer is actually the result of overdiagnosis. Advances have also been made in the treatment of differentiated thyroid cancer, including improvements in radioiodine therapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
Franssila, K. O. & Harach, H. R. Occult papillary carcinoma of the thyroid in children and young adults. A systemic autopsy study in Finland. Cancer 58, 715–719 (1986).
Udelsman, R. & Zhang, Y. The epidemic of thyroid cancer in the United States: the role of endocrinologists and ultrasounds. Thyroid http://dx.doi.org/10.1089/thy.2013.0257.
Li, N., Du, X. L., Reitzel, L. R., Xu, L. & Sturgis, E. M. Impact of enhanced detection on the increase in thyroid cancer incidence in the United States: review of incidence trends by socioeconomic status within the surveillance, epidemiology, and end results registry, 1980–2008. Thyroid 23, 103–110 (2013).
Morris, L. G., Sikora, A. G., Tosteson, T. D. & Davies, L. The increasing incidence of thyroid cancer: the influence of access to care. Thyroid 23, 885–891 (2013).
Guay, B., Johnson-Obaseki, S. E., McDonald, J. T., Connell, C. & Corsten, M. Incidence of differentiated thyroid cancer by socioeconomic status and urban residence: Canada 1991–2006. Thyroid http://dx.doi.org/10.1089/thy.2013.0308.
Lee, T. J., Kim, S., Cho, H. J. & Lee, J. H. The incidence of thyroid cancer is affected by the characteristics of a healthcare system. J. Korean Med. Sci. 27, 1491–1498 (2012).
Sabra, M. M. et al. Clinical outcomes and molecular profile of differentiated thyroid cancers with radioiodine-avid distant metastases. J. Clin. Endocrinol. Metab. 98, E829–E836 (2013).
Ho, A. L. et al. Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer. N. Engl. J. Med. 368, 623–632 (2013).
Reiners, C. et al. Twenty-five years after Chernobyl: outcome of radioiodine treatment in children and adolescents with very high-risk radiation-induced differentiated thyroid carcinoma. J. Clin. Endocrinol. Metab. 98, 3039–3048 (2013).
Kim, C. et al. The risk of second cancers after diagnosis of primary thyroid cancer is elevated in thyroid microcarcinomas. Thyroid 23, 575–582 (2013).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Reiners, C. Advances in our understanding of differentiated thyroid cancer. Nat Rev Endocrinol 10, 69–70 (2014). https://doi.org/10.1038/nrendo.2013.247
Published:
Issue date:
DOI: https://doi.org/10.1038/nrendo.2013.247
